188 related articles for article (PubMed ID: 35677052)
1. Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer.
Zecca A; Barili V; Olivani A; Biasini E; Boni C; Fisicaro P; Montali I; Tiezzi C; Dalla Valle R; Ferrari C; Cariani E; Missale G
Front Immunol; 2022; 13():875072. PubMed ID: 35677052
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
Kalathil SG; Thanavala Y
Cells; 2021 May; 10(6):. PubMed ID: 34071188
[TBL] [Abstract][Full Text] [Related]
3. Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy.
Xiao R; Tian Y; Zhang J; Li N; Qi M; Liu L; Wang J; Li Z; Zhang J; Zhao F; Wang T; Tan S; Li C; Wu Z; Yu M; Jiang X; Zhan P; Gao L; Han B; Liu X; Liang X; Ma C
J Hepatol; 2024 May; 80(5):792-804. PubMed ID: 38331327
[TBL] [Abstract][Full Text] [Related]
4. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
[TBL] [Abstract][Full Text] [Related]
5. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.
Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495
[TBL] [Abstract][Full Text] [Related]
7. IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction.
Easom NJW; Stegmann KA; Swadling L; Pallett LJ; Burton AR; Odera D; Schmidt N; Huang WC; Fusai G; Davidson B; Maini MK
Front Immunol; 2018; 9():1009. PubMed ID: 29867983
[TBL] [Abstract][Full Text] [Related]
8. [Research progress on immunotherapy based on NK cells for hepatocellular carcinoma].
Zhu X; Zhou Y; Zhu S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jan; 40(1):80-88. PubMed ID: 38246181
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin2 enhances the tumoricidal function of liver natural killer cells in a mouse hepatocellular carcinoma model.
Chen M; Xu M; Zhu C; Wang H; Zhao Q; Zhou F
Cancer Immunol Immunother; 2019 Jun; 68(6):961-971. PubMed ID: 30955067
[TBL] [Abstract][Full Text] [Related]
10. The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.
Sajid M; Liu L; Sun C
Front Immunol; 2022; 13():887186. PubMed ID: 35669776
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
Wu M; Mei F; Liu W; Jiang J
Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
[TBL] [Abstract][Full Text] [Related]
13. Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.
Zecca A; Barili V; Rizzo D; Olivani A; Biasini E; Laccabue D; Dalla Valle R; Ferrari C; Cariani E; Missale G
Cells; 2021 Mar; 10(3):. PubMed ID: 33802077
[TBL] [Abstract][Full Text] [Related]
14. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
Yu M; Luo H; Fan M; Wu X; Shi B; Di S; Liu Y; Pan Z; Jiang H; Li Z
Mol Ther; 2018 Feb; 26(2):366-378. PubMed ID: 29339014
[TBL] [Abstract][Full Text] [Related]
15. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
16. 2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis.
Pan B; Chen Z; Zhang X; Wang Z; Yao Y; Wu X; Qiu J; Lin H; Yu L; Tu H; Tang N
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37316264
[TBL] [Abstract][Full Text] [Related]
17. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C; Sun H; Zhang C; Tian Z
Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
[TBL] [Abstract][Full Text] [Related]
18. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated NK cells facilitate tumor growth via NKp46 in immunocompetent murine hepatocellular carcinoma.
Guan X; Lu Y; Zhang Y; Zhan P; Chen Z; Wang C; Yin Z
Immunol Lett; 2023 Jun; 258():8-19. PubMed ID: 37121554
[TBL] [Abstract][Full Text] [Related]
20. Clinical-scale isolation of interleukin-2-stimulated liver natural killer cells for treatment of liver transplantation with hepatocellular carcinoma.
Ohira M; Nishida S; Tryphonopoulos P; Tekin A; Selvaggi G; Moon J; Levi D; Ricordi C; Ishiyama K; Tanaka Y; Ohdan H; Tzakis AG
Cell Transplant; 2012; 21(7):1397-406. PubMed ID: 22469170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
